Profound circulatory collapse due to azathioprine' G A C Major FRACP P G Moore FFARACS Departments ofRheumatology and Intensive Care Royal Newcastle Hospital, Newcastle, Australia Azathioprine is a widely used and generally well tolerated immunosuppressive agent. Its major adverse effect is bone marrow suppression, particularly when higher doses are used (Whisnant & Pelkey 1982) . Occasionally, however, pancreatitis (Nogueira & Freedman 1972) , hepatotoxicity (Davis et al. 1980) , acute renal insufficiency (Sloth & Thomsen 1971) , hypotension (Cunningham et al. 1981 ) and hypersensitivity reactions characterized by fever, nausea, -muscle and joint pains and erythematous rash (King et al. 1972 ) can also occur. We describe a patient in whom rechallenge after a suspected acute hypersensitivity reaction led to profound circulatory collapse, jaundice, acute renal failure and later pancreatitis.
Case report
A 45-year-old woman, with a 20-year history of active rheumatoid arthritis (RA) unresponsive to a range of second-line agents, developed fever, severe malaise, epigastric pains and vomiting six days after commencing treatment with azathioprine (Imuran®) 100 mg per day. She was admitted to her local hospital where she was found to be mildly hypotensive and jaundiced. In addition to azathioprine she was taking enteric-coated aspirin, indomethacin suppositories (which were stopped) and prednisone (which was continued at a dose of 10 mg per day). She was given intravenous fluids and amoxycillin. After 24 hours the amoxycillin was withdrawn because of the development of an erythematous rash and she was continued on fluids alone, making an apparently complete recovery within four days.
Two weeks later she developed a recrudescence of her RA and was admitted for physiotherapy and reintroduction of drug therapy. Indomethacin and then aspirin were restarted without adverse effect. On her eighth hospital day she was given a single 50 mg tablet of Imuran® as a test dose. Twelve hours after ingestion of the azathioprine she developed a fever of 39-8°C and her blood pressure fell to 90/50 mmHg. Intravenous fluids were given. Her blood pressure remained at this level for 8 hours, and then fell to an unrecordable level.
Following transfer to intensive care she was given a dopamine infusion and 2 g of methylprednisolone. Additional measures included the infusion of plasma protein solution and NaHCO3 'Accepted 14 June 1985 0141-0768/85/121052-02/$02.00/0 to correct metabolic acidosis (pH 7.298, actual HCO3 -10 mmol/l, base excess -14). Her blood pressure rose to 90/60 mmHg with a pulse rate of 150 per minute. Haemodynamic measurements with the aid of a pulmonary artery catheter demonstrated a cardiac output of4.73 I/min, mean pulmonary artery pressure of 21 mmHg and pulmonary capillary wedge pressure of 12 mmHg. She became severely oliguric, and serum creatinine rose from a previously normal 0.07 mmol/I to 0.30 mmol/l. At 24 hours she showed ECG and pyrophosphate 'hot spot' scan evidence of anterolateral wall infarction. Her condition then stabilized, with an increase in urine output, and by the fifth day serum creatinine levels had returned to normal.
Other abnormalities noted during this illness were a mild elevation of serum bilirubin and glutamic oxaloacetic transaminase (SGOT). This occurred 24 hours after azathioprine ingestion and returned to normal over the following 48 hours. Also at about 24 hours a diffuse erythematous rash appeared on the trunk and limbs and persisted for 8 hours before spontaneous resolution.
Cultures of blood and urine taken on the first day showed no growth. On the sixth postchallenge day, a rise was noted in the serum amylase, which peaked on day 8 at,919u/I and returned to normal over the following eleven days. There was no associated hypotension and the usual signs of acute severe pancreatitis were not observed. There was no disturbance of blood sugar levels.
Discussion
The problems experienced by our patient on initial exposure to azathioprine are similar to those described in earlier reports of adverse reaction to this drug (King et al. 1972) . Though the variety and severity of problems encountered on rechallenge have not previously been reported in a single patient, they have all been observed in individual cases-before. The chronological sequence, and the recurrence of the initial reactions on rechallenge, all indicate a drug-induced event. Whilst the mechanism underlying these reactions is not known, most authors have postulated a hypersensitivity process, with the parent molecule or a metabolite acting as a possible hapten (Sloth & Thomsen 1971) . The occurrence of the initial reaction six days after the start of treatment and the accelerated onset (12 hours) on rechallenge are certainly consistent with an immune reaction and parallel the classic phases of a period of silent antibody build up to new antigen culminating in a reaction, with immediate reaction due to preformed antibody on re-exposure.
The delay in the onset of pancreatitis need not rule out such an explanation. Though a direct Journal ofthe Royal Society ofMedicine Volume 78 December 1985 1053 stimulatory effect on exocrine pancreatic function has been demonstrated by Broe & Cameron (1983) in a canine model, the delay actually favours a hypersensitivity process, the complication occurring as it did in the absence of ongoing drug exposure.
Azathioprine can have a critical role in the treatment of a number of conditions, and the potential loss of the agent due to suspected hypersensitivity may pose severe limitations on management. Because of the relatively nonspecific nature of these reactions, rechallenge may be warranted under such circumstances. The experience of the present patient, however, illustrates that such practice is attended by serious risk and should only be contemplated under strictly controlled conditions andAvith the ready availability of full resuscitation facilities.
Small cell carcinoma of the bronchus: a rare cause of haematuria from a metastasis in the urinary bladder' right hilar mass strongly suggestive of a primary bronchial carcinoma, but sputum cytology revealed no malignant cells. In view of her symptoms and poor overall condition, she was treated promptly with oral prednisone 30 mg daily and palliative radiotherapy. She received 3600 cGY midplane dose in 9 fractions over 21 days with parallel opposed megavoltage fields to the mediastinum and supraclavicular fossae. Six weeks after radiotherapy, the venous obstruction and the nodal disease had subsided.
Three months later she required a cystoscopy to investigate painless haematuria. A solid 3 cm 
